Clinical Trial: CBD Provided Pain Relief Comparable to Codeine-Acetaminophen After …

A randomized controlled trial demonstrated that cannabidiol (CBD) monotherapy provided analgesia equivalent to the combination of codeine and acetaminophen in postoperative pain management, suggesting CBD may serve as an effective alternative opioid-sparing analgesic for acute pain conditions. The trial’s findings are particularly relevant given the ongoing public health concern regarding opioid dependence and adverse effects associated with traditional analgesic combinations. Concurrent regulatory developments, including recent medical cannabis licensing legislation in Washington, D.C., are expanding the legal framework for cannabis-based therapeutics, which may improve patient access to these alternatives in select jurisdictions. For clinicians, these findings indicate that CBD warrants consideration as a non-opioid option for postoperative and acute pain management, though further research on optimal dosing, long-term safety, and patient selection criteria remains necessary. The combination of clinical efficacy data and improving regulatory pathways suggests the cannabis landscape is shifting toward evidence-based integration into mainstream pain management protocols. Clinicians should remain informed about CBD efficacy and local regulations to counsel patients appropriately about this emerging analgesic option.

💬 Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →

Have thoughts on this? Share it:

• THC and CBD Edibles More Effective at Pain Relief Than CBD Alone
• Cannabis Formula Granted “Breakthrough Therapy Designation” by FDA for Pain Treatment
• Repurposing Medicinal Cannabis Compounds for Cystitis Pain Relief